0001104659-22-003158.txt : 20220111 0001104659-22-003158.hdr.sgml : 20220111 20220111160741 ACCESSION NUMBER: 0001104659-22-003158 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220107 FILED AS OF DATE: 20220111 DATE AS OF CHANGE: 20220111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mastrocola Lauren CENTRAL INDEX KEY: 0001827639 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39620 FILM NUMBER: 22523959 MAIL ADDRESS: STREET 1: C/O PRAXIS PRECISION MEDICINES, INC. STREET 2: ONE BROADWAY, 16TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Praxis Precision Medicines, Inc. CENTRAL INDEX KEY: 0001689548 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HIGH STREET, 30TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-300-8460 MAIL ADDRESS: STREET 1: 99 HIGH STREET, 30TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 4 1 tm222494-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-01-07 0 0001689548 Praxis Precision Medicines, Inc. PRAX 0001827639 Mastrocola Lauren C/O PRAXIS PRECISION MEDICINES, INC. 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110 0 1 0 0 Principal Accounting Officer Common Stock 2022-01-07 4 A 0 6000 0 A 26418 D Stock Option (Right to Buy) 18.11 2022-01-07 4 A 0 21000 0 A 2032-01-07 Common Stock 21000 21000 D Ms. Mastrocola was awarded 6,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 7, 2023, subject to the reporting person's continued service through each vesting date. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. The shares underlying this stock option vest over a four-year period, with 25% vesting on January 7, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. /s/ Alex Nemiroff, as Attorney-in-Fact 2022-01-11